These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30441657)

  • 21. The effect of two different high-flux dialysis membranes on insulin resistance in non-diabetic end-stage renal disease patients.
    Kara M; Gurluler E; Cakır U
    Ren Fail; 2015; 37(8):1293-6. PubMed ID: 26399977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved preservation of residual renal function in chronic hemodialysis patients using polysulfone dialyzers.
    McCarthy JT; Jenson BM; Squillace DP; Williams AW
    Am J Kidney Dis; 1997 Apr; 29(4):576-83. PubMed ID: 9100048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of a Novel Dialyzer Containing a Fluorinated Polyurethane Surface-Modifying Macromolecule in Patients with End-Stage Kidney Disease.
    Meyer JM; Steer D; Weber LA; Zeitone AA; Thakuria M; Ho CH; Aslam S; Mullon C; Kossmann RJ
    Blood Purif; 2021; 50(6):959-967. PubMed ID: 33789265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized controlled pilot study of 2 weeks' treatment with high cutoff membrane for hemodialysis patients with elevated C-reactive protein.
    Fiedler R; Neugebauer F; Ulrich C; Wienke A; Gromann C; Storr M; Böhler T; Seibert E; Girndt M
    Artif Organs; 2012 Oct; 36(10):886-93. PubMed ID: 22845695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reconsidering adsorption in hemodialysis: is it just an epiphenomenon? A narrative review.
    Florens N; Guebre-Egziabher F; Juillard L
    J Nephrol; 2022 Jan; 35(1):33-41. PubMed ID: 33837932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of hemodialysis on some parameters of the antioxidant system in the blood of patients with chronic renal failure].
    Olszewska M
    Ann Acad Med Stetin; 2004; 50(1):41-52. PubMed ID: 16871743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Timing of dialysis initiation, duration and frequency of hemodialysis sessions, and membrane flux: a systematic review for a KDOQI clinical practice guideline.
    Slinin Y; Greer N; Ishani A; MacDonald R; Olson C; Rutks I; Wilt TJ
    Am J Kidney Dis; 2015 Nov; 66(5):823-36. PubMed ID: 26498415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of membrane composition and structure on solute removal and biocompatibility in hemodialysis.
    Clark WR; Hamburger RJ; Lysaght MJ
    Kidney Int; 1999 Dec; 56(6):2005-15. PubMed ID: 10594776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationale and Strategies for Preserving Residual Kidney Function in Dialysis Patients.
    Li T; Wilcox CS; Lipkowitz MS; Gordon-Cappitelli J; Dragoi S
    Am J Nephrol; 2019; 50(6):411-421. PubMed ID: 31630148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the impact of high-flux dialysis on mortality in hemodialysis patients with and without residual renal function.
    Kim HW; Kim SH; Kim YO; Jin DC; Song HC; Choi EJ; Kim YL; Kim YS; Kang SW; Kim NH; Yang CW; Kim YK
    PLoS One; 2014; 9(6):e97184. PubMed ID: 24906205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double tangential flow filtration-based microfluidic device for highly efficient separation and enrichment of exosomes.
    Hua X; Zhu Q; Liu Y; Zhou S; Huang P; Li Q; Liu S
    Anal Chim Acta; 2023 Jun; 1258():341160. PubMed ID: 37087290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dialysis membranes for blood purification.
    Sakai K
    Front Med Biol Eng; 2000; 10(2):117-29. PubMed ID: 10898241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymeric nanofiber web-based artificial renal microfluidic chip.
    Lee KH; Kim DJ; Min BG; Lee SH
    Biomed Microdevices; 2007 Aug; 9(4):435-42. PubMed ID: 17265147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Twice-Weekly Hemodialysis With Adjuvant Pharmacotherapy and Transition to Thrice-Weekly Hemodialysis: A Pilot Study.
    Murea M; Patel A; Highland BR; Yang W; Fletcher AJ; Kalantar-Zadeh K; Dressler E; Russell GB
    Am J Kidney Dis; 2022 Aug; 80(2):227-240.e1. PubMed ID: 34933066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanoporous silicon nitride membranes fabricated from porous nanocrystalline silicon templates.
    DesOrmeaux JP; Winans JD; Wayson SE; Gaborski TR; Khire TS; Striemer CC; McGrath JL
    Nanoscale; 2014 Sep; 6(18):10798-805. PubMed ID: 25105590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of protein leaking BK-F PMMA-based hemodialysis on plasma pentosidine levels.
    Tessitore N; Lapolla A; Aricò NC; Poli A; Gammaro L; Bassi A; Bedogna V; Corgnati A; Reitano R; Fedele D; Lupo A
    J Nephrol; 2004; 17(5):707-14. PubMed ID: 15593039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Solute Transport in Hemodialysis: Advances and Limitations of Current Membrane Technology.
    Clark WR; Gao D; Neri M; Ronco C
    Contrib Nephrol; 2017; 191():84-99. PubMed ID: 28910793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of hemodialysis with frequent use of cuprophan and polysulfone membranes on activation of complement in patients with chronic renal failure].
    Zukowska-Szczechowska E; Moczulski D; Grzeszczak W; Gosek K; Augustyn M; Staszewicz P
    Pol Arch Med Wewn; 1996 Nov; 96(5):458-68. PubMed ID: 9091856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do high-flux dialysis membranes affect renal dyslipidemia?
    Ottosson P; Attman PO; Knight C; Samuelsson O; Weiss L; Alaupovic P
    ASAIO J; 2001; 47(3):229-34. PubMed ID: 11374763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological basis of hypoalbuminemia in ESRD.
    Kaysen GA
    J Am Soc Nephrol; 1998 Dec; 9(12):2368-76. PubMed ID: 9848794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.